Product

Introduction

Telmisartan Tablets IP 40 mg, marketed under the brand name TELP*-40, contain 40 mg of telmisartan, an angiotensin II receptor blocker used to treat essential hypertension in adults and reduce cardiovascular morbidity in patients with atherothrombotic cardiovascular disease or type 2 diabetes mellitus with target organ damage. The usual effective dose for hypertension is 40 mg once daily, with some patients benefiting from a daily dose of 20 mg. The dosage can be increased to a maximum of 80 mg once daily if the target blood pressure is not achieved. Telmisartan may also be used in combination with diuretics for enhanced blood pressure control. In cardiovascular prevention, the recommended dose is 80 mg once daily, with close monitoring of blood pressure and potential adjustments to other antihypertensive medications. Telmisartan has a long half-life of about 24 hours, ensuring sustained blood pressure control with once-daily dosing.

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat. Ut wisi enim ad minim veniam, quis nostrud exerci tation ullamcorper suscipit lobortis nisl ut aliquip ex ea commodo consequat. Duis autem vel eum iriure dolor in hendrerit in vulputate velit esse molestie consequat, vel illum dolore eu feugiat nulla facilisis at vero eros et accumsan et iusto odio dignissim qui blandit praesent luptatum zzril delenit augue duis dolore te feugait nulla facilisi.
Lorem ipsum dolor sit amet, cons ectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat. Ut wisi enim ad minim veniam, quis nostrud exerci tation ullamcorper suscipit lobortis nisl ut aliquip ex ea commodo consequat.